
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs2.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC50000459136AA04B6.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="emm" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC9534909/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534909/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Experimental &#x00026; Molecular Medicine" /><meta name="citation_title" content="BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity" /><meta name="citation_author" content="Seung-Hyun Bae" /><meta name="citation_author_institution" content="Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea" /><meta name="citation_author" content="Jung-Hoon Kim" /><meta name="citation_author_institution" content="Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea" /><meta name="citation_author_institution" content="Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, 10408 Republic of Korea" /><meta name="citation_author" content="Tae Hyun Park" /><meta name="citation_author_institution" content="Department of Anesthesiology, Weill Cornell Medical College, New York, NY 10065 USA" /><meta name="citation_author" content="Kyeong Lee" /><meta name="citation_author_institution" content="College of Pharmacy, Dongguk University-Seoul, Goyang, 10326 Republic of Korea" /><meta name="citation_author" content="Byung Il Lee" /><meta name="citation_author_institution" content="Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea" /><meta name="citation_author_institution" content="Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, 10408 Republic of Korea" /><meta name="citation_author" content="Hyonchol Jang" /><meta name="citation_author_institution" content="Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea" /><meta name="citation_author_institution" content="Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, 10408 Republic of Korea" /><meta name="citation_publication_date" content="2022/09" /><meta name="citation_issue" content="9" /><meta name="citation_volume" content="54" /><meta name="citation_firstpage" content="1450" /><meta name="citation_doi" content="10.1038/s12276-022-00840-x" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC9534909/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC9534909/" /><meta name="citation_pmid" content="36056187" /><meta name="DC.Title" content="BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Korean Society for Biochemistry and Molecular Biology" /><meta name="DC.Contributor" content="Seung-Hyun Bae" /><meta name="DC.Contributor" content="Jung-Hoon Kim" /><meta name="DC.Contributor" content="Tae Hyun Park" /><meta name="DC.Contributor" content="Kyeong Lee" /><meta name="DC.Contributor" content="Byung Il Lee" /><meta name="DC.Contributor" content="Hyonchol Jang" /><meta name="DC.Date" content="2022 Sep" /><meta name="DC.Identifier" content="10.1038/s12276-022-00840-x" /><meta name="DC.Language" content="en" /><meta property="og:title" content="BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity" /><meta property="og:type" content="article" /><meta property="og:description" content="Myeloid epithelial reproductive proto-oncogene tyrosine kinase (MERTK) plays an essential role in modulating cancer immune tolerance by regulating macrophage efferocytosis. Studies are underway to develop small-molecule chemicals that inhibit MERTK as ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534909/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9534909/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/872/">Exp Mol Med</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/418614/">v.54(9); 2022 Sep</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC9534909
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC9534909/pdf/12276_2022_Article_840.pdf" class="int-view">PDF (6.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/9534909/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/9534909/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="9534909" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9534909%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="tGkmxj1QaS5Ttom3Sgx5QI8oCoWwLSOmtzYaGLwrR8oXSJFChayOsYS61k9qNxvD">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9534909%2F&amp;text=BMS794833%20inhibits%20macrophage%20efferocytosis%20by%20directly%20binding%20to%20MERTK%20and%20inhibiting%20its%20activity" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9534909%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534909/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC9534909/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/36056187/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC9534909/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/36056187/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC9534909/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/9534909/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/872/">Exp Mol Med</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/418614/">v.54(9); 2022 Sep</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC9534909
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-emm.gif" alt="Logo of emm" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.nature.com/emm/index.html" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Exp Mol Med.</span> 2022 Sep; 54(9): 1450–1460. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2022 Sep 2. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1038%2Fs12276-022-00840-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1038/s12276-022-00840-x</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC9534909</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36056187">36056187</a></div></div></div><h1 class="content-title">BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Bae%20SH%5BAuthor%5D" class="affpopup" co-rid="_co_idm140431451552480" co-class="co-affbox">Seung-Hyun Bae</a>,<sup>#</sup><sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kim%20JH%5BAuthor%5D" class="affpopup" co-rid="_co_idm140431451550256" co-class="co-affbox">Jung-Hoon Kim</a>,<sup>#</sup><sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Park%20TH%5BAuthor%5D" class="affpopup" co-rid="_co_idm140431465803712" co-class="co-affbox">Tae Hyun Park</a>,<sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20K%5BAuthor%5D" class="affpopup" co-rid="_co_idm140431465801728" co-class="co-affbox">Kyeong Lee</a>,<sup>4</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20BI%5BAuthor%5D" class="affpopup" co-rid="_co_idm140431457959632" co-class="co-affbox">Byung Il Lee</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>2</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jang%20H%5BAuthor%5D" class="affpopup" co-rid="_co_idm140431457955552" co-class="co-affbox">Hyonchol Jang</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140431451552480"><h3 class="no_margin">Seung-Hyun Bae</h3><p><sup>1</sup>Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Bae%20SH%5BAuthor%5D">Seung-Hyun Bae</a></div></div><div id="_co_idm140431451550256"><h3 class="no_margin">Jung-Hoon Kim</h3><p><sup>1</sup>Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea </p><p><sup>2</sup>Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, 10408 Republic of Korea </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kim%20JH%5BAuthor%5D">Jung-Hoon Kim</a></div></div><div id="_co_idm140431465803712"><h3 class="no_margin">Tae Hyun Park</h3><p><sup>3</sup>Department of Anesthesiology, Weill Cornell Medical College, New York, NY 10065 USA </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Park%20TH%5BAuthor%5D">Tae Hyun Park</a></div></div><div id="_co_idm140431465801728"><h3 class="no_margin">Kyeong Lee</h3><p><sup>4</sup>College of Pharmacy, Dongguk University-Seoul, Goyang, 10326 Republic of Korea </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20K%5BAuthor%5D">Kyeong Lee</a></div></div><div id="_co_idm140431457959632"><h3 class="no_margin">Byung Il Lee</h3><p><sup>1</sup>Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea </p><p><sup>2</sup>Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, 10408 Republic of Korea </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20BI%5BAuthor%5D">Byung Il Lee</a></div></div><div id="_co_idm140431457955552"><h3 class="no_margin">Hyonchol Jang</h3><p><sup>1</sup>Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea </p><p><sup>2</sup>Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, 10408 Republic of Korea </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jang%20H%5BAuthor%5D">Hyonchol Jang</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140431451592016_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140431451592016_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140431451592016_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140431451592016_ai" style="display:none"><div class="fm-affl" id="Aff1"><sup>1</sup>Reasearch Institute, National Cancer Center, Goyang, 10408 Republic of Korea </div><div class="fm-affl" id="Aff2"><sup>2</sup>Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, 10408 Republic of Korea </div><div class="fm-affl" id="Aff3"><sup>3</sup>Department of Anesthesiology, Weill Cornell Medical College, New York, NY 10065 USA </div><div class="fm-affl" id="Aff4"><sup>4</sup>College of Pharmacy, Dongguk University-Seoul, Goyang, 10326 Republic of Korea </div><div><span class="fm-affl">Byung Il Lee, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rk.er.ccn@eelib" class="oemail">rk.er.ccn@eelib</a></span>.</div><div><a href="#article-aaff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140431451592016_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2022 May 12; Revised 2022 Jun 13; Accepted 2022 Jun 24.</div></div><div class="permissions half_rhythm hide" id="idm140431451592016_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author(s) 2022</div><div class="license half_rhythm"><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="9" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Information</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">12276_2022_840_MOESM1_ESM.pdf</a><span style="color:gray"> (547K)</span></div><div class="small guid">GUID: 0BD1D62C-7888-4F99-AB9C-D91AD037AF07</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Movie 1</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM2_ESM.avi" data-ga-action="click_feat_suppl">12276_2022_840_MOESM2_ESM.avi</a><span style="color:gray"> (2.4M)</span></div><div class="small guid">GUID: 50E439FA-118F-4FED-BFAB-B7E4D3E55D0C</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Movie 2</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM3_ESM.avi" data-ga-action="click_feat_suppl">12276_2022_840_MOESM3_ESM.avi</a><span style="color:gray"> (2.5M)</span></div><div class="small guid">GUID: EAEAA5BD-31A7-4BDD-97EC-251DF0830A3C</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Movie 3</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM4_ESM.avi" data-ga-action="click_feat_suppl">12276_2022_840_MOESM4_ESM.avi</a><span style="color:gray"> (2.6M)</span></div><div class="small guid">GUID: 05D17258-67C2-474D-9613-5501A73B0CC3</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Movie 4</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM5_ESM.avi" data-ga-action="click_feat_suppl">12276_2022_840_MOESM5_ESM.avi</a><span style="color:gray"> (2.6M)</span></div><div class="small guid">GUID: C7FD45C1-2210-4EC9-B40D-F641F41B6708</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Movie 5</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM6_ESM.avi" data-ga-action="click_feat_suppl">12276_2022_840_MOESM6_ESM.avi</a><span style="color:gray"> (2.7M)</span></div><div class="small guid">GUID: D92E0517-D7B3-47F1-9557-CA66C15F9C75</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Movie 6</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM7_ESM.avi" data-ga-action="click_feat_suppl">12276_2022_840_MOESM7_ESM.avi</a><span style="color:gray"> (2.8M)</span></div><div class="small guid">GUID: 1CB87424-A832-4CDB-98B0-ADE07E80DB93</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Movie 7</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM8_ESM.avi" data-ga-action="click_feat_suppl">12276_2022_840_MOESM8_ESM.avi</a><span style="color:gray"> (3.0M)</span></div><div class="small guid">GUID: F1EE442D-CDDA-45F7-86EC-18D524BA629A</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Movie 8</div><div><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM9_ESM.avi" data-ga-action="click_feat_suppl">12276_2022_840_MOESM9_ESM.avi</a><span style="color:gray"> (3.0M)</span></div><div class="small guid">GUID: 4BE905D5-B5C1-4273-9422-6BBE64EFF2E7</div></div></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><p id="Par1" class="p p-first-last">Myeloid epithelial reproductive proto-oncogene tyrosine kinase (MERTK) plays an essential role in modulating cancer immune tolerance by regulating macrophage efferocytosis. Studies are underway to develop small-molecule chemicals that inhibit MERTK as cancer immunotherapeutic agents, but these efforts are in their early stages. This study identified BMS794833, whose primary targets are MET and VEGFR2, as a potent MERTK inhibitor and developed a real-time efferocytosis monitoring system. The X-ray cocrystal structure revealed that BMS794833 was in contact with the ATP-binding pocket and the allosteric back pocket, rendering MERTK inactive. Homogeneous time-resolved fluorescence kinetic and Western blotting analyses showed that BMS794833 competitively inhibited MERTK activity in vitro and inhibited the autophosphorylation of MERTK in macrophages. We developed a system to monitor MERTK-dependent efferocytosis in real time, and using this system, we confirmed that BMS794833 significantly inhibited the efferocytosis of differentiated macrophages. Finally, BMS794833 significantly inhibited efferocytosis in vivo in a mouse model. These data show that BMS794833 is a type II MERTK inhibitor that regulates macrophage efferocytosis. In addition, the real-time efferocytosis monitoring technology developed in this study has great potential for future applications.</p></div><div class="sec"><strong class="kwd-title">Subject terms: </strong><span class="kwd-text">Biochemistry, Cell biology</span></div></div><div id="Abs2" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs2title">Cancer: drug could block evading the immune system</h2><!--article-meta--><div><p id="Par2" class="p p-first-last">An enzyme that is over-expressed in cancers and helps promote immune evasion could be inhibited by a small-molecule anticancer drug currently in phase 1 clinical trials. White blood cells called macrophages rapidly clear dead cells to avoid inappropriate inflammatory responses in a process known as efferocytosis. The MERTK enzyme receptor, expressed by macrophages, plays a key role. However, MERTK is over-expressed in many cancers, leading to aberrant efferocytosis and immune evasion. Using mouse models, Hyonchol Jang and Byung Il Lee at the National Cancer Center, Goyang, South Korea, and co-workers demonstrated that the drug BMS794833 is an effective inhibitor of MERTK-dependent efferocytosis. Using X-ray crystallography, they determined that the drug binds to and inactivates MERTK. To potentially identify other MERTK inhibitors, they also developed a novel assay that monitors efferocytosis in real time.</p></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="Par3" class="p p-first">Apoptotic cells are rapidly cleared via phagocytes to prevent inappropriate inflammatory responses and maintain physiological homeostasis in a process known as efferocytosis<sup><a href="#CR1" rid="CR1" class=" bibr popnode">1</a>,<a href="#CR2" rid="CR2" class=" bibr popnode">2</a></sup>. Efferocytosis is conducted by macrophages that express many receptors, including <span class="underline">m</span>yeloid <span class="underline">e</span>pithelial <span class="underline">r</span>eproductive proto-oncogene <span class="underline">t</span>yrosine <span class="underline">k</span>inase (MERTK)<sup><a href="#CR1" rid="CR1" class=" bibr popnode">1</a></sup>. MERTK is a member of the TAM (<span class="underline">T</span>YRO3, <span class="underline">A</span>XL, and <span class="underline">M</span>ERTK) receptor tyrosine kinase family. These kinases play essential roles in immune homeostasis and are involved in regulating the innate immune response, restoring vascular integrity, and efferocytosis by different phagocytic cell types<sup><a href="#CR3" rid="CR3" class=" bibr popnode">3</a>,<a href="#CR4" rid="CR4" class=" bibr popnode">4</a></sup>. The role of MERTK in regulating efferocytosis is most prominent among the TAM family, considering that clearance of apoptotic thymocytes is reduced in <em>Mertk</em><sup><em>&#x02013;/</em>&#x02013;</sup> mice but normal in <em>Axl/Tyro3</em><sup><em>&#x02013;/&#x02013;</em></sup> mice<sup><a href="#CR4" rid="CR4" class=" bibr popnode">4</a>,<a href="#CR5" rid="CR5" class=" bibr popnode">5</a></sup>. MERTK is activated by autophosphorylation when protein S or growth arrest-specific 6 (GAS6) ligands that bind to phosphatidylserine (PtdSer) are exposed on the surface of dying or dead cells bind to MERTK. Macrophages with activated MERTK begin to engulf apoptotic cells through actin reorganization<sup><a href="#CR3" rid="CR3" class=" bibr popnode">3</a></sup>. They also engulf foreign antigens through phagocytosis, but whether MERTK participates in this process is unclear.</p><p id="Par4">MERTK is aberrantly expressed in various cancers and promotes tumor immune evasion and M2 polarization of macrophages through the regulation of efferocytosis<sup><a href="#CR6" rid="CR6" class=" bibr popnode">6</a></sup>. Studies on <em>Mertk</em><sup><em>&#x02013;/</em>&#x02013;</sup> mice, small-molecule MERTK inhibitors, and MERTK-specific antibodies have demonstrated that MERTK inhibition has an anticancer effect and that regulation of efferocytosis is a key mechanism<sup><a href="#CR6" rid="CR6" class=" bibr popnode">6</a>&#x02013;<a href="#CR8" rid="CR8" class=" bibr popnode">8</a></sup>. To develop MERTK inhibitors as anticancer drugs, it is necessary to confirm whether candidate substances inhibit efferocytosis by inhibiting MERTK. Recently, human monocytes were extracted and differentiated into macrophages to monitor the efferocytosis ability of macrophages in vitro<sup><a href="#CR9" rid="CR9" class=" bibr popnode">9</a></sup>. However, it is time-consuming and difficult to obtain a sufficient number of monocytes. In addition, it is not known whether the decrease in the efferocytosis ability of macrophages is due to MERTK inhibition. Therefore, a system to easily monitor MERTK-dependent efferocytosis is needed.</p><p id="Par5">Structural studies of eukaryotic protein kinase domains have reported characteristic conformational changes in the conserved Asp-Phe-Gly (DFG) motif and the &#x003b1;C-helix (&#x003b1;C) during enzymatic activation<sup><a href="#CR10" rid="CR10" class=" bibr popnode">10</a>&#x02013;<a href="#CR12" rid="CR12" class=" bibr popnode">12</a></sup>. Therefore, the active/inactive state of kinases can be determined by DFG and &#x003b1;C conformation: the active conformation of kinases should adopt the &#x0201c;DFG flip-in&#x0201d; and &#x0201c;&#x003b1;C swing-in&#x0201d; conformation; all other conformations in DFG and &#x003b1;C are inactive kinases. ATP competitive protein kinase inhibitors can be classified into three types. Type I inhibitors bind to the ATP-binding pocket of the active conformation of kinases that have DFG-in and &#x003b1;C-in structures, type II kinase inhibitors bind to the inactive DFG-out conformation, and type I1/2 inhibitors bind to the inactive DFG-in conformation with an &#x003b1;C-out form<sup><a href="#CR13" rid="CR13" class=" bibr popnode">13</a></sup>.</p><p id="Par6">Some small molecules with MERTK inhibitory effects have been used clinically, but in all cases, MERTK is not their primary target, and in most cases, their binding mode with MERTK has not been clearly elucidated. Some small molecules that primarily target MERTK are in clinical trials, but in all cases, their binding mode with MERTK has not been clearly elucidated by X-ray crystallography. MERTK inhibitors with clearly defined binding modes, except for gilteritinib, AZD7762, and merestinib, have advanced at most to the preclinical stage. Moreover, the primary targets of gilteritinib, AZD7762, and merestinib are not MERTK but FLT3, CHEK1, and MET, respectively<sup><a href="#CR14" rid="CR14" class=" bibr popnode">14</a>&#x02013;<a href="#CR16" rid="CR16" class=" bibr popnode">16</a></sup>. Thus, the development of anticancer drugs that specifically inhibit MERTK is still at an early stage.</p><p id="Par7" class="p p-last">In this study, we investigated the binding mode between MERTK and BMS794833 through X-ray crystallography. BMS794833 is a small molecule in phase I clinical trials with BMS817378, a prodrug of BMS794833 that targets advanced or metastatic solid tumors (ClinicalTrials.gov identifier: <a id="__tag_1123834391" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00792558" ref="reftype=extlink-clinical-trial&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00792558","term_id":"NCT00792558"}}</span>NCT00792558</a>), in which the primary targets are MET and VEGFR2<sup><a href="#CR17" rid="CR17" class=" bibr popnode">17</a></sup>. We also developed a system to monitor MERTK-dependent efferocytosis using monocyte cell line-derived macrophages in real time. BMS794833 inhibited MERTK activity in vitro and in cells and inhibited efferocytosis in cells and animals.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Materials and methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Cloning and protein purification</h3><p id="Par8" class="p p-first-last">Whole cloning and purification protocols followed a previous report<sup><a href="#CR15" rid="CR15" class=" bibr popnode">15</a></sup>. In a biochemical activity assay, the gene coding the N-terminal His<sub>6</sub> tag-thrombin-MERTK kinase domain (residues 571&#x02013;864, wild type; WT) was subcloned into the pETDuet-1-PTPN1 (pETDuet-1 vector containing the PTPN1 (1&#x02013;330) gene at MCS2, Merck Millipore, USA) bacterial expression vector using the Nco1 and Not1 cloning sites at MCS1. In addition, surface entropy reduction mutations were introduced (GSHM-MERTK K591R/K693R/K702R/K856R; KR mutant)<sup><a href="#CR18" rid="CR18" class=" bibr popnode">18</a></sup> via site-directed mutagenesis to improve the quality of the protein crystals.</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Crystallization and structure determination</h3><p id="Par9" class="p p-first">All crystals were prepared via the sitting-drop vapor-diffusion method using Mosquito&#x000ae; (SPT Labtech, UK) at 14&#x02009;&#x000b0;C. MERTK native crystals were obtained with 15&#x02009;mg/mL purified recombinant MERTK (KR mutant) and a crystallization reservoir solution of 0.1&#x02009;M Tris-HCl pH 8.5 and 4.3&#x02009;M NaCl. Microseeding increased the crystal size and improved the diffraction quality. Native crystals were obtained within a day but grown fully for 5&#x02013;7 days.</p><p id="Par10">To obtain ligand-bound forms of MERTK, crystals were prepared by the seeding method. Freshly thawed MERTK:BMS794833 (25&#x02009;mg/mL protein and 2&#x02009;mM ligand) was incubated for 2&#x02009;h under ice-cold conditions. Crystallization was achieved following the same protocol described above. Nine days after crystallization started, the crystals were transferred to a cryoprotectant solution (0.1&#x02009;M Tris-HCl pH 8.5, 2.5&#x02009;M NaCl, 20% DMSO, and 10&#x02009;mM BMS794833) for X-ray diffraction experiments.</p><p id="Par11" class="p p-last">Diffraction data were collected using a Dectris Pilatus 6&#x02009;M CCD detector at the beamline-11C experimental station at the Pohang Accelerator Laboratory (Korea). The structure was solved by molecular replacement with the PHASER program<sup><a href="#CR19" rid="CR19" class=" bibr popnode">19</a></sup> using the MERTK kinase domain structure (PDB code 7AAX<sup><a href="#CR18" rid="CR18" class=" bibr popnode">18</a></sup>) as the search model. Repeated rounds of manual model building and crystallographic refinement were performed using COOT<sup><a href="#CR20" rid="CR20" class=" bibr popnode">20</a></sup> and PHENIX<sup><a href="#CR21" rid="CR21" class=" bibr popnode">21</a></sup>. The topology and parameter files of the inhibitor were built by the Electronic Ligand Builder and Optimization Workbench (eLBOW) suite in PHENIX. The inhibitor was fitted to 2mF<sub>o</sub>-Df<sub>c</sub> electron density, and further refinement cycling was repeated. The refinement statistics are summarized in Supplementary Table <a href="#MOESM1" rid="MOESM1" class=" media">1</a>.</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">HTRF-based MERTK kinetic assays</h3><p id="Par12" class="p p-first-last">Kinetic assays for the MERTK kinase domain were conducted using a homogeneous time-resolved fluorescence (HTRF) KinEASE-TK kit (Cisbio, USA) as described previously<sup><a href="#CR15" rid="CR15" class=" bibr popnode">15</a></sup>. Freshly thawed MERTK WT was serially diluted and used at 1&#x02009;ng/&#x003bc;L (final) for the assay. We added 5&#x02009;mM MgCl<sub>2</sub>, 1&#x02009;mM DTT, and 0.2% DMSO to the reaction buffer. The enzymatic reaction mixture was incubated for 120&#x02009;min at 37&#x02009;&#x000b0;C. Time-resolved fluorescence intensities were recorded by TECAN SPARK with an excitation wavelength of 320&#x02009;nm and two emission wavelengths of 620 and 650&#x02009;nm. The integration and lag times were used as the default settings (400 and 100 &#x003bc;s for each). The IC<sub>50</sub> values for the inhibitor were determined at 30&#x02009;&#x003bc;M (close to <em>K</em><sub>m</sub>) and 1&#x02009;mM ATP (at the cellular level) with an inhibitor concentration of 0.000067&#x02013;4&#x02009;&#x003bc;M. Independent triplicate assay experiments confirmed the reproducibility of the assays.</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Cell cultures</h3><p id="Par13" class="p p-first-last">All cell lines were purchased from the Korean Cell Line Bank (Seoul, Korea). THP-1, U-937, and Jurkat cells were cultured in RPMI-1640 medium (HyClone, USA) supplemented with 10% heat-inactivated fetal bovine serum (HyClone, USA), 1% penicillin/streptomycin (Invitrogen, USA), and 1&#x000d7; 2-mercaptoethanol (Gibco, USA) in T25 or T75 flasks at 37&#x02009;&#x000b0;C in a humidified incubator containing 5% CO<sub>2</sub>. The cells were authenticated and checked for <em>mycoplasma</em> at the Genomics Core Facility (National Cancer Center, Korea) as described previously<sup><a href="#CR22" rid="CR22" class=" bibr popnode">22</a></sup>.</p></div><div id="Sec7" class="sec"><h3 id="Sec7title">Real-time monitoring of efferocytosis and phagocytosis</h3><p id="Par14" class="p p-first">A total of 50,000 THP-1 and U-937 cells were differentiated into macrophages by treatment with 100&#x02009;nM phorbol-12-myristate 13-acetate (PMA; Sigma, USA) for 2 days in each well of a 96-well Cellcarrier Ultra microplate (Perkin Elmer, Germany). Simultaneously, to induce apoptosis, Jurkat cells were treated with 50&#x02009;&#x000b5;M cisplatin (Sigma, USA) in a T75 flask for 2 days. Jurkat cells were stained with 50&#x02009;ng/mL pHrodo&#x02122; Red and succinimidyl ester (pHrodo-SE; Thermo Fisher Scientific, USA) for 1&#x02009;h, and then 200,000 cells/well were added to the macrophage culture wells. If necessary, inhibitors were used to treat macrophages 1&#x02009;h before the addition of Jurkat cells. Images were obtained using Operetta CLS&#x02122; (Perkin Elmer, Germany) at a 1&#x02009;h interval for 24&#x02009;h and analyzed with Harmony 4.6 software (Perkin Elmer, Germany).</p><p id="Par15" class="p p-last">For the phagocytosis assay, differentiated macrophages were added to 20&#x02009;&#x003bc;g of pHrodo&#x02122; Red <em>S</em>. <em>aureus</em> Bioparticles&#x02122; (pHrodo-particles; Thermo Fisher Scientific, USA) per well instead of stained Jurkat cells. The pHrodo&#x02122; Red dye is pH-sensitive; it is colorless at neutral pH but acquires red fluorescence (Ex/Em &#x003bb;: 560/585&#x02009;nm) in acidic environments of approximate pH 5&#x02013;6. Macrophages swallowing pHrodo-SE-stained apoptotic cells or pHrodo-particles exhibit red fluorescence.</p></div><div id="Sec8" class="sec"><h3 id="Sec8title">Mice and in vivo efferocytosis assay</h3><p id="Par16" class="p p-first-last">Female C57BL/6&#x02009;N mice were purchased from Orient Bio (Seongnam, Korea). All mice were acclimatized for 2 weeks at the laboratory animal research facility (National Cancer Center, Korea). The mice were administered 25&#x02009;mg/kg BMS794833 (Cayman, USA) or control (5% DMSO, 10% kolliphor in PBS) by intraperitoneal injection. After 30&#x02009;min, 8&#x02009;mg/kg dexamethasone (Selleckchem, USA) was administered to the mice by intraperitoneal injection to induce thymus apoptosis. The thymus was collected and dissociated into a single-cell suspension as previously described in refs. <sup><a href="#CR4" rid="CR4" class=" bibr popnode">4</a>,<a href="#CR23" rid="CR23" class=" bibr popnode">23</a></sup>. The thymocytes were analyzed by annexin V and propidium iodide staining and flow cytometry at the Flow Cytometry Core Facility (National Cancer Center, Korea) using FACSVerse (BD Bioscience, USA) as described previously<sup><a href="#CR24" rid="CR24" class=" bibr popnode">24</a></sup>.</p></div><div id="Sec9" class="sec"><h3 id="Sec9title">Chemical treatment and Western blotting</h3><p id="Par17" class="p p-first-last">Each chemical treatment was administered 4&#x02009;h prior to protein extraction. Cells were harvested and washed in PBS and then lysed in a buffer containing 20&#x02009;mM Tris-HCl (pH 7.4), 150&#x02009;mM NaCl, 1% (v/v) Triton X-100, 1&#x02009;mM EDTA, a protease inhibitor cocktail (genDEPOT, USA), and a phosphatase inhibitor cocktail (genDEPOT, USA). Western blotting was performed according to a modified version of a previously described method<sup><a href="#CR25" rid="CR25" class=" bibr popnode">25</a></sup>. After SDS&#x02013;PAGE and protein transfer, the desired protein was detected using an iBind&#x02122; Automated Western system (Thermo Fisher Scientific, USA). Equal concentrations of UNC2250 were used as a positive control. Full immunoblots are shown in Supplementary Fig. <a href="#MOESM1" rid="MOESM1" class=" media">2</a>. The antibodies and chemicals used in this study are summarized in Supplementary Table <a href="#MOESM1" rid="MOESM1" class=" media">2</a>.</p></div><div id="Sec10" class="sec"><h3 id="Sec10title">RNAi</h3><p id="Par18" class="p p-first-last">Small interfering RNAs (siRNAs) targeting MERTK and AXL and the negative control were designed and synthesized by BIONEER (Daejeon, Korea). THP-1 macrophages were transfected with siRNA using jetPRIME transfection reagent (Polyplus, France) according to the manufacturer&#x02019;s protocol. The siRNA sequences used in this study are summarized in Supplementary Table <a href="#MOESM1" rid="MOESM1" class=" media">3</a>.</p></div><div id="Sec11" class="sec sec-last"><h3 id="Sec11title">Statistical analyses</h3><p id="Par19" class="p p-first-last">Statistical analysis was performed as reported previously<sup><a href="#CR26" rid="CR26" class=" bibr popnode">26</a></sup>. The data were presented as the means&#x02009;&#x000b1;&#x02009;standard deviations, and <em>P</em> values were calculated using a Student&#x02019;s <em>t</em>-test calculator (<a href="http://graphpad.com/quickcalcs/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://graphpad.com/quickcalcs/</a>). The data are representative of at least three separate experiments.</p></div></div><div id="Sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec12title">Results</h2><div id="Sec13" class="sec sec-first"><h3 id="Sec13title">The X-ray cocrystal structure shows the binding mode of BMS794833 to MERTK</h3><p id="Par20" class="p p-first">Previously, a thermal shift assay using purified MERTK kinase domains in an in-house kinase-inhibitor library revealed that 8 of 356 compounds exhibited a melting temperature shift of &#x0003e;1&#x02009;&#x000b0;C<sup><a href="#CR15" rid="CR15" class=" bibr popnode">15</a></sup>. Among them, BMS794833 (IUPAC name; <em>N</em>-[4-(2-amino-3-chloropyridin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-4-oxo-1<em>H</em>-pyridine-3-carboxamide; Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.1a),</span></span><span>1a</span></a>), which is currently being studied in phase I clinical trial as a treatment for advanced solid tumors, was co-crystallized with the MERTK kinase domain. The X-ray crystal structure was determined at a resolution of 2.16&#x02009;&#x000c5; (Supplementary Table <a href="#MOESM1" rid="MOESM1" class=" media">1</a>). The clear electron density map for BMS794833 showed that it occupied both the ATP-binding pocket and the allosteric back pocket (also called the hydrophobic patch) (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1b</span></span><span>1b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140431500256112"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9534909_12276_2022_840_Fig1_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12276_2022_840_Fig1_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9534909/bin/12276_2022_840_Fig1_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140431500256112"><a target="object" rel="noopener" href="/pmc/articles/PMC9534909/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig. 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Chemical structure of BMS794833 and the X-ray crystal structure bound to MERTK.</strong><p><strong>a</strong> The chemical structure of BMS794833. <strong>b</strong> BMS794833 occupies the kinase domain binding pockets from the ATP-binding pocket to the allosteric back pocket. The 2mF<sub>o</sub>-DF<sub>c</sub> omit map is shown with a 1.5 &#x003c3; contour level; BMS794833 showed good occupancy within the MERTK kinase domain. <strong>c</strong> The interacting hydrogen bonds between the MERTK kinase domain and BMS794833 are depicted as blue dashed lines, and hydrophobic interactions are depicted as yellow dashed lines. <strong>d</strong> The surface representation of the entrance region of the allosteric back pocket, also known as the hydrophobic patch. Left, the representation of hydrophobicity generated by a &#x0201c;color_h&#x0201d; script based on the previously defined hydrophobicity scale (left)<sup><a href="#CR48" rid="CR48" class=" bibr popnode">48</a></sup>. Right, the representation of qualitative electrostatic potential by the &#x0201c;vacuum electrostatics&#x0201d; command in the program PyMOL.</p></div></div></div><p id="Par21">The main interacting forces are four hydrogen bonds (H bonds) and six hydrophobic interactions. BMS794833 formed two H bonds with the ATP-binding site and two H bonds with the allosteric back pocket of MERTK. The amine and imine at the 3-chloropyridin of BMS794833 formed H bonds with the main chain of Met674 of the ATP-binding site (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1c).</span></span><span>1c</span></a>). The allosteric back pocket region consists of ~10 residues, of which only Lys619 and Asp741 participate in the H bond. Two oxygens in the 4-oxo-1,4-dihydropyridine-3-carboxamide group of BMS794833 formed H bonds with the side chain of Lys619 and the main chain amine of Asp741 (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1c).</span></span><span>1c</span></a>). Three benzene ring moieties in BMS794833, namely, 3-chloropyridin-2-amine, 1-fluoro-2-methoxybenzene, and fluorobenzene, formed hydrophobic interactions with the residues of the allosteric back pocket (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1c).</span></span><span>1c</span></a>). Specifically, 3-chloropyridine-2-amine interacts with Ala617, 1-fluoro-2-methoxybenzene interacts with Leu671 (gatekeeper) and Phe742, and fluorobenzene interacts with Ile650, Asp741, and Phe719. The solvent-exposed gate of the hydrophobic patch was mostly negatively charged and hydrophilic, while the inside of the hydrophobic patch was neutral and hydrophobic (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1d</span></span><span>1d</span></a>).</p><p id="Par22" class="p p-last">It is noteworthy that the H bond and hydrophobic interactions between BMS794833 and Asp741 lock the inactive conformation of the DFG motif by flipping the side chain of Asp741 out of the ATP-binding site of MERTK (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1c).</span></span><span>1c</span></a>). No salt bridge was formed between Lys619 at the &#x003b2;3 strand and Glu637 at the &#x003b1;C, which is essential for the active conformation<sup><a href="#CR10" rid="CR10" class=" bibr popnode">10</a>,<a href="#CR12" rid="CR12" class=" bibr popnode">12</a></sup>, and the &#x003b1;C-helix extended outward from the ATP-binding site (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1c).</span></span><span>1c</span></a>). These results show that BMS794833 binds to the inactive form of MERTK as a type II inhibitor.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Comparison of published complex crystal structures of inhibitors and MERTK</h3><p id="Par23" class="p p-first">The MERTK:BMS794833 complex was compared to 31 other MERTK:inhibitor complex structures deposited in the Protein Data Bank (PDB). Most MERTK inhibitors were type I1/2 (24 of 31), and some were type II (4 of 31). Some inhibitors (3 of 31) could not be determined because of a missing &#x003b1;C-helix structure (Supplementary Table <a href="#MOESM1" rid="MOESM1" class=" media">4</a>).</p><p id="Par24">All of the MERTK inhibitors that bind only to the ATP pocket were classified as type I1/2 with DFG-in and &#x003b1;C-out conformations; we found no typical type I inhibitors with DFG-in and &#x003b1;C-in conformations in the PDB. MERTK bound to AMP-PNP (an ATP analog compound) has a DFG-in conformation, but a salt bridge between the side chain of Glu637 in &#x003b1;C and the side chain of Lys619 in the &#x003b2;3 strand was impaired, resulting in an &#x003b1;C-out conformation and consequent inactivity (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2a).</span></span><span>2a</span></a>). Of the inhibitors that bind only to the ATP pocket (16 out of 31), only gilteritinib (PDB code 7AB1) and AZD7762 (PDB code 7CQE) have entered clinical trials, and MERTK structures in complexes with these two inhibitors are very similar to the AMP-PNP-bound MERTK structure (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2b,</span></span><span>2</span></a>b, <a href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">b,c</span></span><span>c</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140431457866784"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9534909_12276_2022_840_Fig2_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12276_2022_840_Fig2_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9534909/bin/12276_2022_840_Fig2_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140431457866784"><a target="object" rel="noopener" href="/pmc/articles/PMC9534909/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Fig. 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Comparison of published complex crystal structures of inhibitors and MERTK.</strong><p>The chemical structures of ligand molecules bound to MERTK are illustrated at the top, and key residues for ligand interaction are shown at the bottom. The conformations of the DFG motif and &#x003b1;C are also shown on the left. The ligands are <strong>a</strong> AMP-PNP, <strong>b</strong> gilteritinib, <strong>c</strong> AZD7762, <strong>d</strong> chemical 32, <strong>e</strong> LDC1267, and <strong>f</strong> merestinib. Hydrogen bonds are shown as blue dashed lines. Hydrophobic and water- and metal-mediated polar interactions between ligands and interacting residues are also shown in yellow.</p></div></div></div><p id="Par25">Considering that the ATP pockets of many kinases are similar, binding to additional pockets to increase specificity would be advantageous. Some type I1/2 inhibitor structures deposited in the PDB show that a series of MERTK inhibitors occupy the ATP and allosteric back pockets of MERTK (8 out of 31). For example, Chemical 32 (PDB code 7OLX; 1,3,4-oxadiazole, pyridine, 1,3,5-trimethyl-1H-pyrazole) developed by AstraZeneca occupies the allosteric back pocket; imines at 1,3,4-oxadiazole and pyridine form strong H bonds with Asp741 to establish the active form with the DFG-in conformation. In addition, the methyl group of 1,3,5-trimethyl-1H-pyrazole forms a hydrophobic interaction with Ala638, displacing the &#x003b1;C-out (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2d</span></span><span>2d</span></a>).</p><p id="Par26">All type II inhibitors (4 out of 31) deposited in the PDB simultaneously bind to the ATP pocket and the allosteric back pocket of MERTK. Three inhibitors can be classified as typical type II, with DFG-out and &#x003b1;C-out conformations. For example, in LDC1267 (PDB code 7AAX), the DFG motif in the inactive form showed the DFG-out position, DFG-Phe was turned inward to the ATP-binding site, and DFG-Asp was flipped out to the allosteric back pocket (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2e).</span></span><span>2e</span></a>). Merestinib (PDB code 7AAY) has a unique feature in which DFG-out and &#x003b1;C-in form a canonical salt bridge (Lys619 and Glu637) (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2f).</span></span><span>2f</span></a>). 1,6-Dimethylpyridin-2(1H)-one forms a hydrophobic interaction with Glu637 at &#x003b1;C, turning the &#x003b1;C-helix inward to show the active conformation; however, many hydrophobic and H bond interactions between merestinib and Asp741 and Phe742 stabilize the DFG-out conformation to lock the inactive conformation.</p><p id="Par27" class="p p-last">BMS794833 is a typical type II inhibitor with a DFG-out and &#x003b1;C-out conformation (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1c),</span></span><span>1c</span></a>), with a similar binding mode to MERTK as LDC1267 but similar to merestinib in its chemical structure (Figs. <a href="/pmc/articles/PMC9534909/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Figs.1a,</span></span><span>1</span></a>a, <a href="/pmc/articles/PMC9534909/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">a,2f).</span></span><span>2f</span></a>). BMS794833 and merestinib show high similarity in the core scaffold (with a significant difference in the additive moieties of the 2-fluorophenol ring). Due to this high similarity, they show similar occupancies in the ATP and allosteric back binding pockets, but the interacting residues differ. The carbonyl group in an acetamide is the same for BMS794833 and merestinib; however, BMS794833 forms an H bond with Lys619, hindering the formation of a salt bridge with &#x003b1;C, while merestinib does not.</p></div><div id="Sec15" class="sec"><h3 id="Sec15title">BMS794833 inhibits MERTK kinase activity in vitro and in cells</h3><p id="Par28" class="p p-first-last">Based on the clear binding mode of MERTK and BMS794833, we performed HTRF kinetic assays to ascertain how BMS794833 inhibits MERTK. We found that BMS794833 inhibits MERTK in an ATP competitive inhibition mode with a <em>K</em><sub>i</sub> value of 22.4&#x02009;nM (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3a</span></span><span>3a</span></a> and Table <a href="/pmc/articles/PMC9534909/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1).</span></span><span>1</span></a>). The IC<sub>50</sub> values for the inhibitor at ATP concentrations near <em>K</em><sub>m</sub> (30&#x02009;&#x003bc;M)<sup><a href="#CR15" rid="CR15" class=" bibr popnode">15</a></sup> and intracellular ATP levels (1&#x02009;mM) were 28.7&#x02009;nM (&#x000b1;1.2&#x02009;nM) and 129.9&#x02009;nM (&#x000b1;3.2&#x02009;nM), respectively (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3b,</span></span><span>3</span></a>b, <a href="/pmc/articles/PMC9534909/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">b,c).</span></span><span>c</span></a>). BMS794833 also inhibited all TAM family proteins at low ATP concentrations but inhibited MERTK most effectively at intracellular ATP concentrations (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3d).</span></span><span>3d</span></a>). Next, we investigated whether BMS79488 inhibited MERTK activity in cells. The human monocyte cell line THP-1 was differentiated into macrophages by phorbol-12-myristate 13-acetate (PMA) treatment, and MERTK was expressed only under PMA treatment (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3e).</span></span><span>3e</span></a>). The intracellular activity of MERTK can be monitored through autophosphorylation of the Y749, Y753, and Y754 residues<sup><a href="#CR27" rid="CR27" class=" bibr popnode">27</a></sup>. In Western blotting analyses, the MERTK phosphorylation band of THP-1 macrophages was significantly reduced by treatment with 1&#x02009;&#x003bc;M BMS794833, whereas UNC2250, a selective MERTK inhibitor<sup><a href="#CR28" rid="CR28" class=" bibr popnode">28</a></sup>, inhibited MERTK at 10&#x02009;&#x003bc;M (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3e</span></span><span>3e</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC9534909/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140431451843664"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9534909_12276_2022_840_Fig3_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12276_2022_840_Fig3_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9534909/bin/12276_2022_840_Fig3_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140431451843664"><a target="object" rel="noopener" href="/pmc/articles/PMC9534909/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC9534909/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Fig. 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>BMS794833 inhibits MERTK kinase activity both in vitro and in cells.</strong><p><strong>a</strong> Michaelis&#x02013;Menten curve for MERTK kinase activity at different BMS794833 concentrations. <strong>b</strong>, <strong>c</strong> IC<sub>50</sub> values of BMS794833 at ATP concentrations near its <em>K</em><sub>m</sub> (30&#x02009;&#x003bc;M) and near the intracellular level (1&#x02009;mM). <strong>d</strong> The IC<sub>50</sub> of BMS794833 in the TAM family. <strong>e</strong> THP-1 monocytes were differentiated by treatment with 100&#x02009;nM PMA for 2 days. The indicated concentrations of BMS794833 and UNC2250 were administered 4&#x02009;h prior to cell harvesting, and the expression levels of MERTK and phosphorylated MERTK (Y749, Y753, and Y754) were evaluated by Western blotting. &#x003b2;-Actin was used as a loading control. *Nonspecific bands. Relative intensities of phosphorylated MERTK bands normalized to MERTK bands are shown on the right. The values are presented as the mean&#x02009;&#x000b1;&#x02009;SD from three independent experiments. ***<em>P</em>&#x02009;&#x0003c;&#x02009;0.001; ns not significant.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Michaelis&#x02013;Menten kinetics of MERTK at different BMS794833 concentrations.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">BMS794833</th><th rowspan="1" colspan="1">0&#x02009;nM</th><th rowspan="1" colspan="1">10&#x02009;nM</th><th rowspan="1" colspan="1">20&#x02009;nM</th><th rowspan="1" colspan="1">30&#x02009;nM</th><th rowspan="1" colspan="1">40&#x02009;nM</th><th rowspan="1" colspan="1">50&#x02009;nM</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><em>V</em><sub>max</sub></td><td rowspan="1" colspan="1">20,805&#x02009;&#x000b1;&#x02009;488</td><td rowspan="1" colspan="1">20,871&#x02009;&#x000b1;&#x02009;176</td><td rowspan="1" colspan="1">20,242&#x02009;&#x000b1;&#x02009;178</td><td rowspan="1" colspan="1">20,948&#x02009;&#x000b1;&#x02009;265</td><td rowspan="1" colspan="1">21,462&#x02009;&#x000b1;&#x02009;141</td><td rowspan="1" colspan="1">21,639&#x02009;&#x000b1;&#x02009;361</td></tr><tr><td rowspan="1" colspan="1"><em>K</em><sub>m</sub> (&#x003bc;M)</td><td rowspan="1" colspan="1">23.52&#x02009;&#x000b1;&#x02009;0.54</td><td rowspan="1" colspan="1">26.88&#x02009;&#x000b1;&#x02009;0.63</td><td rowspan="1" colspan="1">36.98&#x02009;&#x000b1;&#x02009;1.30</td><td rowspan="1" colspan="1">54.52&#x02009;&#x000b1;&#x02009;0.30</td><td rowspan="1" colspan="1">65.86&#x02009;&#x000b1;&#x02009;0.82</td><td rowspan="1" colspan="1">79.45&#x02009;+&#x02009;3.21</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140431460841440"><a target="object" rel="noopener" href="/pmc/articles/PMC9534909/table/Tab1/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec16" class="sec"><h3 id="Sec16title">Real-time efferocytosis assay using human monocyte cell lines</h3><p id="Par29" class="p p-first">Next, we determined whether BMS794833 inhibited the activity of MERTK sufficiently to affect the physiological outcomes of cells. MERTK inhibition must inhibit efferocytosis in macrophages to have an anticancer effect<sup><a href="#CR7" rid="CR7" class=" bibr popnode">7</a></sup>. To this end, we established real-time efferocytosis assays using the THP-1 and U-937 human monocyte cell lines. Monocytes proliferate in suspension culture, but they lose proliferation ability and become adherent when differentiated into macrophages<sup><a href="#CR29" rid="CR29" class=" bibr popnode">29</a></sup>. Immunofluorescent staining with an antibody specific for CD11b, known as a macrophage marker<sup><a href="#CR29" rid="CR29" class=" bibr popnode">29</a></sup>, showed that most THP-1 and U-937 cells were differentiated into macrophages when 100&#x02009;nM PMA was administered for 48&#x02009;h (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4a</span></span><span>4a</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140431443651408"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9534909_12276_2022_840_Fig4_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12276_2022_840_Fig4_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9534909/bin/12276_2022_840_Fig4_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140431443651408"><a target="object" rel="noopener" href="/pmc/articles/PMC9534909/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Fig. 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Real-time efferocytosis monitoring system with human-derived monocytic cell lines.</strong><p><strong>a</strong> CD11b expression in THP-1 and U-937 cells was investigated by immunocytochemistry. Cells were treated with 100&#x02009;nM PMA (or DMSO) for 48&#x02009;h. <strong>b</strong> Schematic representation of efferocytosis and phagocytosis assays. <strong>c</strong>, <strong>d</strong> Time-lapse microscopy and relative intensity of THP-1 and U-937 macrophages after coculture with nonviable Jurkat cells stained with pHrodo-SE for efferocytosis or pHrodo-particles for phagocytosis <strong>e</strong>, <strong>f</strong>. Merged images were obtained at 6&#x02009;h intervals starting at 0&#x02009;h of the coculture. Each zoomed-in view of the selected area is marked in red. The values are presented as the mean&#x02009;&#x000b1;&#x02009;SD from at least three independent experiments. ***<em>P</em>&#x02009;&#x0003c;&#x02009;0.001. Scale bar: 100&#x02009;&#x003bc;m.</p></div></div></div><p id="Par30">We investigated whether monocyte-derived macrophages exhibit efferocytosis and phagocytosis. Apoptotic Jurkat cells stained with pHrodo-SE were added to macrophages to test for efferocytosis (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4b).</span></span><span>4b</span></a>). Exposure of PtdSer to the surface of apoptotic cells induces macrophage efferocytosis<sup><a href="#CR30" rid="CR30" class=" bibr popnode">30</a></sup>. Because the pHrodo&#x02122; Red dye fluoresces only in an acidic environment, it appears red only when swallowed by macrophages. Cisplatin treatment was used to induce apoptosis in Jurkat cells to generate apoptotic cells for efferocytosis assays<sup><a href="#CR31" rid="CR31" class=" bibr popnode">31</a>,<a href="#CR32" rid="CR32" class=" bibr popnode">32</a></sup>. Flow cytometry analysis after Annexin V and propidium iodide staining showed that cisplatin treatment at 50&#x02009;&#x003bc;M for 2 days resulted in ~95% nonviable cells, and most of these were positive for Annexin V (Supplementary Fig. <a href="#MOESM1" rid="MOESM1" class=" media">1a</a>, <a href="#MOESM1" rid="MOESM1" class=" media">b</a>). After pHrodo-SE staining and coculture with THP-1 and U-937 monocyte-derived macrophages, red fluorescence increased over time when apoptotic cells were added but not when viable cells were added (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4c,</span></span><span>4c</span></a>, Supplementary Fig. <a href="#MOESM1" rid="MOESM1" class=" media">1c</a>, and Supplementary Movies <a href="#MOESM2" rid="MOESM2" class=" media">1</a>&#x02013;<a href="#MOESM6" rid="MOESM6" class=" media">5</a>). The red fluorescence intensity was saturated at 24&#x02009;h. Nonviable Jurkat cells stained with pHrodo-SE alone did not show red fluorescence. These results demonstrate that the extent of efferocytosis over time can be monitored effectively using THP-1 and U-937 monocyte-derived macrophages. In addition, because efferocytosis occurs more frequently in THP-1 cells than in U-937 cells (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4d),</span></span><span>4d</span></a>), THP-1 cells appear to be more suitable for observing the extent of efferocytosis.</p><p id="Par31" class="p p-last">For the phagocytosis analysis, pHrodo-particles were added to macrophages (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4b).</span></span><span>4b</span></a>). The gram-positive commensal <em>S</em>. <em>aureus</em> bacterium induces macrophage recruitment, polarization, and phagocytosis<sup><a href="#CR33" rid="CR33" class=" bibr popnode">33</a></sup>. THP-1 and U-937 monocyte-derived macrophages to which we added pHrodo-particles showed an increase in red fluorescence over time, whereas PHrodo-particles alone did not (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4e,</span></span><span>4e</span></a>, Supplementary Fig. <a href="#MOESM1" rid="MOESM1" class=" media">1d</a>, and Supplementary Movies <a href="#MOESM7" rid="MOESM7" class=" media">6</a>&#x02013;<a href="#MOESM9" rid="MOESM9" class=" media">8</a>). Unlike efferocytosis, phagocytosis occurred more frequently in U-937 cells than in THP-1 cells (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4f</span></span><span>4f</span></a>).</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">Efferocytosis of THP-1 macrophages depends on MERTK activity</h3><p id="Par32" class="p p-first">As we established real-time monitoring systems for efferocytosis and phagocytosis, we determined whether these phenomena depended on MERTK activity. First, the Western blotting analysis showed that MERTK was not expressed in THP-1 monocytes but was expressed in differentiated macrophages. Detection of MERTK autophosphorylation suggested that MERTK was activated in THP-1 monocyte-derived macrophages (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5a).</span></span><span>5a</span></a>). However, the expression of AXL decreased with the differentiation of THP-1 monocytes, and TYRO3 expression was not detected (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5a),</span></span><span>5a</span></a>), suggesting that MERTK has a pivotal role among the TAM family members in THP-1 monocyte-derived macrophages. In U-937 cells, MERTK and TYRO3 were expressed in monocytes, but their expression decreased after differentiation, and AXL was not detected (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5a</span></span><span>5a</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140431448580528"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9534909_12276_2022_840_Fig5_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12276_2022_840_Fig5_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9534909/bin/12276_2022_840_Fig5_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140431448580528"><a target="object" rel="noopener" href="/pmc/articles/PMC9534909/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Fig. 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Efferocytosis of THP-1 macrophages depends on MERTK activity.</strong><p><strong>a</strong> Western blotting analysis of THP-1 and U-937 cells to measure the expression levels of the TAM family and MERTK active form (phospho-MERTK). Cells were treated with 100&#x02009;nM PMA (or DMSO). <strong>b</strong>, <strong>c</strong> Images and relative intensity in efferocytosis and phagocytosis assays. Before coculture, the cells were pretreated with 10&#x02009;&#x003bc;M UNC2250 or cytochalasin D for 1&#x02009;h. All of the data were obtained after 24&#x02009;h of coculture. <strong>d</strong> The knockdown efficiency of siMERTKs in THP-1 cells was measured via Western blotting. Each siRNA was applied at a final concentration of 50&#x02009;nM. <strong>e</strong>, <strong>f</strong> Images and relative intensity in efferocytosis and phagocytosis assays. Before coculture, siMERTKs were pretreated with 50&#x02009;nM for 24&#x02009;h. <strong>g</strong> The knockdown efficiency of siAXLs in THP-1 cells was measured via Western blotting analysis. <strong>h</strong>, <strong>i</strong> Images and relative intensity in efferocytosis and phagocytosis assays. The values are presented as the mean&#x02009;&#x000b1;&#x02009;SD from at least three independent experiments. ***<em>P</em>&#x02009;&#x0003c;&#x02009;0.001; ns not significant; Scale bar: 100&#x02009;&#x003bc;m.</p></div></div></div><p id="Par33" class="p p-last">Next, we investigated whether the inhibition of MERTK affects the efferocytosis of THP-1 monocyte-derived macrophages. The addition of UNC2250, a selective MERTK inhibitor<sup><a href="#CR28" rid="CR28" class=" bibr popnode">28</a></sup>, significantly reduced the efferocytosis but not phagocytosis of THP-1 macrophages. As a control, the addition of cytochalasin D, which inhibits actin reorganization by depolymerizing actin filaments<sup><a href="#CR34" rid="CR34" class=" bibr popnode">34</a></sup>, completely inhibited both efferocytosis and phagocytosis (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5b,</span></span><span>5</span></a>b, <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">b,c).</span></span><span>c</span></a>). Knockdown of MERTK by siRNA confirmed by Western blotting (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5d)</span></span><span>5d</span></a>) reduced the efferocytosis but not phagocytosis of THP-1 monocyte-derived macrophages (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5e,</span></span><span>5</span></a>e, <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">e,f).</span></span><span>f</span></a>). In contrast, knockdown of AXL (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5g)</span></span><span>5g</span></a>) did not affect efferocytosis or phagocytosis (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5h,</span></span><span>5</span></a>h, <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">h,i).</span></span><span>i</span></a>). These results suggest that the real-time efferocytosis monitoring system of THP-1 macrophages can be used to test MERTK inhibitor efficacy, as the efferocytosis of THP-1 monocyte-derived macrophages depends on MERTK activity.</p></div><div id="Sec18" class="sec sec-last"><h3 id="Sec18title">BMS794833 inhibits efferocytosis at the cellular and animal levels</h3><p id="Par34" class="p p-first">We investigated whether BMS794833 could inhibit the efferocytosis of macrophages. Treatment with 10&#x02009;&#x003bc;M BMS794833 significantly decreased the efferocytosis of THP-1 monocyte-derived macrophages (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6a,</span></span><span>6</span></a>a, <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">a,b).</span></span><span>b</span></a>). UNC2250, which has an IC<sub>50</sub> of 1.7&#x02009;nM for MERTK in cell-free assays<sup><a href="#CR28" rid="CR28" class=" bibr popnode">28</a></sup>, showed a slightly weaker efferocytosis inhibitory effect than BMS794833 at 10&#x02009;&#x003bc;M (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6a,</span></span><span>6</span></a>a, <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">a,b),</span></span><span>b</span></a>), which proved that BMS794833 is a sufficiently potent inhibitor of MERTK.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140431457571232"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9534909_12276_2022_840_Fig6_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12276_2022_840_Fig6_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9534909/bin/12276_2022_840_Fig6_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140431457571232"><a target="object" rel="noopener" href="/pmc/articles/PMC9534909/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Fig. 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>BMS794833 inhibits efferocytosis at the cellular and animal levels.</strong><p><strong>a</strong>, <strong>b</strong> Images and relative intensity in efferocytosis assays with 10&#x02009;&#x000b5;M UNC2250 or BMS794833. Cells were pretreated with the inhibitors 1&#x02009;h before coculture. All images and data were obtained after 24&#x02009;h of coculture. <strong>c</strong> Schematic depiction of the in vivo efferocytosis assay. Mice were dosed (or not) with BMS794833 30&#x02009;min before dexamethasone treatment. Each thymus was collected and isolated as thymocytes 24&#x02009;h after dexamethasone treatment. <strong>d</strong>, <strong>e</strong> Results of in vivo efferocytosis. Thymocytes were stained with Annexin V and propidium iodide. The values are presented as the mean&#x02009;&#x000b1;&#x02009;SD from at least three independent experiments. **<em>P</em>&#x02009;&#x0003c;&#x02009;0.01, ***<em>P</em>&#x02009;&#x0003c;&#x02009;0.001; ns not significant; scale bar: 100&#x02009;&#x003bc;m; Dex dexamethasone, BMS BMS794833.</p></div></div></div><p id="Par35" class="p p-last">Because BMS794833 has entered clinical trials and is safe for animals, we tested whether it could inhibit efferocytosis in animals. MERTK kinase inhibitors are expected to act similarly in humans and mice, as their respective MERTK kinase domains exhibit high structural similarity and are 94% similar in sequence. An in vivo efferocytosis assay using C57BL/6&#x02009;N immunocompetent mice was performed by observing the clearance of apoptotic thymocytes induced by dexamethasone treatment (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6c).</span></span><span>6c</span></a>). In a previous study, intraperitoneal injection of dexamethasone caused an accumulation of nonviable cells in the thymi of mice 8&#x02009;h after treatment, which was cleared by thymic resident macrophages 24&#x02009;h after treatment<sup><a href="#CR7" rid="CR7" class=" bibr popnode">7</a></sup>. A single dexamethasone treatment somewhat increased the number of apoptotic thymocytes 24&#x02009;h after treatment, suggesting that considerable numbers of apoptotic thymocytes were cleared by efferocytosis. Pretreatment with BMS794833 before dexamethasone treatment significantly increased the percentage of apoptotic thymocytes (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6d,</span></span><span>6</span></a>d, <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">d,e),</span></span><span>e</span></a>), suggesting that BMS794833 inhibits efferocytosis in the thymus. As a control, treatment with BMS794833 alone did not affect the percentage of apoptotic thymocytes (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6d,</span></span><span>6</span></a>d, <a href="/pmc/articles/PMC9534909/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">d,e).</span></span><span>e</span></a>). Overall, these data show that BMS794833 is a type II inhibitor of MERTK and inhibits efferocytosis of macrophages in animals. It has shown great potential for further development as a clinically applicable MERTK inhibitor.</p></div></div><div id="Sec19" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec19title">Discussion</h2><p id="Par36" class="p p-first">Because of the significant potential of MERTK as an anticancer target, many MERTK inhibitors are under development. Three compounds whose X-ray cocrystal structures with MERTK have been revealed have entered clinical trials: AZD7762, gilteritinib, and merestinib. However, further development of AZD7762 was halted due to unpredictable cardiac toxicity<sup><a href="#CR35" rid="CR35" class=" bibr popnode">35</a></sup>. Gilteritinib, whose primary target is FLT3, has been approved by the Food and Drug Administration (FDA) for the treatment of acute myeloid leukemia<sup><a href="#CR14" rid="CR14" class=" bibr popnode">14</a>,<a href="#CR36" rid="CR36" class=" bibr popnode">36</a></sup>. This drug also inhibits several other kinases, such as ALK, LTK, AXL, and MERTK. At 1&#x02009;nM, it inhibits FLT3 by 86.8%, ALK by 76.1%, LTK by 81.8%, AXL by 54.3%, and MERTK by 21.5%, which indicates a relatively weak inhibitory effect on MERTK<sup><a href="#CR37" rid="CR37" class=" bibr popnode">37</a></sup>. Merestinib has passed phase I clinical trials and is now in phase II clinical trials for the treatment of advanced or metastatic biliary tract cancer<sup><a href="#CR38" rid="CR38" class=" bibr popnode">38</a></sup>. Its primary target is MET, but it also inhibits MST1R, FLT3, AXL, PDGFRA, ROS1, TEK, DDR1/2, and MKNK-1/2<sup><a href="#CR16" rid="CR16" class=" bibr popnode">16</a></sup>. This drug is a type II inhibitor of MERTK with DFG-out and &#x003b1;C-in conformations. BMS794833, identified in this study, has entered phase I clinical trials for the treatment of advanced or metastatic solid tumors (ClinicalTrials.gov Identifier: <a id="__tag_1123834390" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00792558" ref="reftype=extlink-clinical-trial&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00792558","term_id":"NCT00792558"}}</span>NCT00792558</a>). Although the primary targets of BMS794833 are MET and VEGFR2<sup><a href="#CR39" rid="CR39" class=" bibr popnode">39</a></sup>, BMS794833 also inhibits the polarization of monocytes into tumor-associated macrophages through a polypharmacological effect rather than inhibition of MET and VEGFR2<sup><a href="#CR40" rid="CR40" class=" bibr popnode">40</a></sup>. BMS794833 is a typical type II inhibitor of MERTK with DFG-out and &#x003b1;C-out structural conformations and inhibits efferocytosis in cells and animal models. Thus, this compound is a promising candidate anticancer agent that inhibits MERTK.</p><p id="Par37">One of the biggest obstacles to developing MERTK inhibitors is the lack of suitable and efficient cell-based assays. Current MERTK inhibitor assays can be roughly divided into three categories. One class measures autophosphorylated MERTK via Western blotting or enzyme-linked immunosorbent assay (ELISA)<sup><a href="#CR41" rid="CR41" class=" bibr popnode">41</a>,<a href="#CR42" rid="CR42" class=" bibr popnode">42</a></sup>. While this clearly shows whether the inhibitor inhibits MERTK, it has the disadvantage of not showing whether the inhibitor inhibits MERTK sufficiently to affect cell physiology. Another class measures the extent to which MERTK inhibition induced cell growth inhibition and death via proliferation assays or cell viability assays<sup><a href="#CR42" rid="CR42" class=" bibr popnode">42</a>,<a href="#CR43" rid="CR43" class=" bibr popnode">43</a></sup>. A disadvantage is that it is unclear whether growth inhibition and death occur in a MERTK-dependent manner. Furthermore, considering that the main role of MERTK is to modulate innate immunity rather than to regulate cell growth and death, it is unclear whether this assay adequately measures the endpoint of MERTK inhibition. The other class measures the extent to which MERTK inhibitors reduce macrophage phagocytosis or efferocytosis<sup><a href="#CR9" rid="CR9" class=" bibr popnode">9</a>,<a href="#CR44" rid="CR44" class=" bibr popnode">44</a></sup>. Among them, phagocytosis assays are problematic because it remains unclear whether MERTK regulates phagocytosis. In this study, we found that MERTK inhibition reduced efferocytosis but did not affect phagocytosis in THP-1 macrophages (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5).</span></span><span>5</span></a>). Therefore, to test the efficacy of MERTK inhibitors, we should investigate efferocytosis and not phagocytosis. The extent of efferocytosis has been analyzed using either monocytes extracted from blood<sup><a href="#CR9" rid="CR9" class=" bibr popnode">9</a></sup> or monocyte cell lines such as THP-1, U-937, and RAW264.7<sup><a href="#CR45" rid="CR45" class=" bibr popnode">45</a>&#x02013;<a href="#CR47" rid="CR47" class=" bibr popnode">47</a></sup>; however, it remains unclear whether the efferocytosis of macrophages differentiated from these monocytes is MERTK-dependent. In this study, THP-1-derived macrophages mainly expressed only MERTK among the TAM family, and efferocytosis occurred in a MERTK-dependent manner (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5).</span></span><span>5</span></a>). On the other hand, U-937-derived macrophages rarely expressed TAM family proteins (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5a),</span></span><span>5a</span></a>), so efferocytosis might occur depending on factors other than the TAM family. Therefore, an efferocytosis assay using THP-1-derived macrophages might be a good method to validate MERTK inhibitors at the cellular level.</p><p id="Par38">Some cells undergo apoptosis during cancer cell growth, and these cells trigger an inflammatory response to induce an immune response. One way cancer cells evade the immune response is by converting the surrounding monocytes into tumor-associated macrophages, which eliminate apoptotic cells through efferocytosis. Recently, it was reported that BMS794833 could block monocyte conversion into tumor-associated macrophages through a mechanism that is not precisely determined<sup><a href="#CR40" rid="CR40" class=" bibr popnode">40</a></sup>. Because MERTK is known to affect tumor-associated macrophage polarization by modulating efferocytosis<sup><a href="#CR8" rid="CR8" class=" bibr popnode">8</a></sup> and this study revealed that BMS794833 is a type II inhibitor that directly binds to MERTK, the blockade of conversion in that study may have been caused by MERTK inhibition. In addition, BMS794833 inhibited cancer growth in immunocompetent animal models<sup><a href="#CR40" rid="CR40" class=" bibr popnode">40</a></sup>. Given these facts, BMS794833 has the potential to be used as an immuno-oncology agent that prevents cancer cells from evading immunity by efferocytosis (Fig. <a href="/pmc/articles/PMC9534909/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.7</span></span><span>7</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC9534909/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140431464996320"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9534909_12276_2022_840_Fig7_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12276_2022_840_Fig7_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9534909/bin/12276_2022_840_Fig7_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140431464996320"><a target="object" rel="noopener" href="/pmc/articles/PMC9534909/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC9534909/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Fig. 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Schematic diagram suggesting BMS794833 as a cancer immunotherapy candidate.</strong><p>The immune response occurs via the activation of inflammatory signals induced by apoptotic cells, which are inevitably generated during cancer cell growth. Cancer cells have been known to evade the immune response by eliminating apoptotic cells through efferocytosis of macrophages. In this study, it was revealed that BMS794833 is a type II inhibitor that directly binds to MERTK and blocks efferocytosis. BMS794833 has the potential to be used as an immuno-oncology agent that prevents cancer cells from evading immunity either by itself or through modifications.</p></div></div></div><p id="Par39" class="p p-last">Overall, this study shows that BMS794833 is a potent and novel MERTK inhibitor that modulates efferocytosis. Efferocytosis occurs in a MERTK-dependent manner in THP-1-derived macrophages, suggesting the possibility of using this assay as a fluorescent-based high-throughput screening process to identify MERTK inhibitors.</p></div><div id="sec-a.v.e" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.v.etitle">Supplementary information</h2><!--/article/body/sec/--><div id="Sec20" class="sec sec-first-last"><p class="p p-first-last">
</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.a.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">Supplementary Information</a><sup>(547K, pdf)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM2"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.b.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM2_ESM.avi" data-ga-action="click_feat_suppl">Supplementary Movie 1</a><sup>(2.4M, avi)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM3"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.c.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM3_ESM.avi" data-ga-action="click_feat_suppl">Supplementary Movie 2</a><sup>(2.5M, avi)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM4"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.d.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM4_ESM.avi" data-ga-action="click_feat_suppl">Supplementary Movie 3</a><sup>(2.6M, avi)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM5"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.e.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM5_ESM.avi" data-ga-action="click_feat_suppl">Supplementary Movie 4</a><sup>(2.6M, avi)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM6"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.f.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM6_ESM.avi" data-ga-action="click_feat_suppl">Supplementary Movie 5</a><sup>(2.7M, avi)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM7"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.g.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM7_ESM.avi" data-ga-action="click_feat_suppl">Supplementary Movie 6</a><sup>(2.8M, avi)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM8"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.h.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM8_ESM.avi" data-ga-action="click_feat_suppl">Supplementary Movie 7</a><sup>(3.0M, avi)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM9"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.i.a"><a href="/pmc/articles/PMC9534909/bin/12276_2022_840_MOESM9_ESM.avi" data-ga-action="click_feat_suppl">Supplementary Movie 8</a><sup>(3.0M, avi)</sup></div></div><p>
</p></div></div><div id="ack-a.w.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.w.ctitle">Acknowledgements</h2><div class="sec"><p>We thank Tae Sik Kim of the Flow Cytometry Core, Mi Ae Kim of the Microscopy Core Facility, and Jung-Ah Hwang of the Genomics Core Facility of the National Cancer Center for their expert assistance. We thank the beamline staff at Pohang Light Source, Korea (BL-11C), for their assistance during the X-ray diffraction experiments. This research was supported by National Cancer Center grants (NCC-2110022 and 2210350 to H.J.) and by National Research Foundation of Korea (NRF) grants funded by the Korean government (MIST) (NRF-2021R1F1A1060602, 2022R1A2C2009720 to H.J. and NRF-2019R1A2C1002545, NRF-2018R1A5A2023127 to B.I.L.).</p></div></div><div id="notes-a.w.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.w.dtitle">Author contributions</h2><p>H.J. and B.I.L. designed the research; S.-H.B., J.-H.K., and T.H.P. performed the experiments; H.J., B.I.L., S.-H.B., and J.-H.K. analyzed and reviewed the data; S.-H.B. and J.-H.K. wrote the draft; and K.L., B.I.L., and H.J. reviewed and edited the manuscript. All the authors reviewed the manuscript and approved the final version.</p></div><div id="FPar1" class="tsec sec"><h2 class="head no_bottom_margin" id="FPar1title">Competing interests</h2><p id="Par40">The authors declare no competing interests.</p></div><div id="FPar2" class="tsec sec"><h2 class="head no_bottom_margin" id="FPar2title">Ethical approval</h2><p id="Par41">This study was reviewed and approved by the Institutional Animal Care and Use Committee of the National Cancer Center Research Institute (NCC-21-689), an Association for Assessment and Accreditation of Laboratory Animal Care International-accredited facility.</p></div><div id="fn-group-a.w.a" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.w.atitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.w.a.a"><p class="p p-first-last"><strong>Publisher&#x02019;s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></p><p class="fn sec" id="fn-a.w.a.b"><p class="p p-first-last">These authors contributed equally: Seung-Hyun Bae, Jung-Hoon Kim.</p></p></div></div><div id="article-aaff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="article-aaff-infotitle">Contributor Information</h2><p><span class="fm-affl">Byung Il Lee, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rk.er.ccn@eelib" class="oemail">rk.er.ccn@eelib</a></span>.</p><p><span class="fm-affl">Hyonchol Jang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rk.er.ccn@gnajh" class="oemail">rk.er.ccn@gnajh</a></span>.</p></div><div id="sec-a.w.b" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="sec-a.w.btitle">Supplementary information</h2><!--/article/back/sec/--><p class="p p-first-last">The online version contains supplementary material available at 10.1038/s12276-022-00840-x.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. <span><span class="ref-journal">Chest. </span>2006;<span class="ref-vol">129</span>:1673–1682. doi: 10.1378/chest.129.6.1673.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16778289" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1378%2Fchest.129.6.1673" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Burying+the+dead:+the+impact+of+failed+apoptotic+cell+removal+(efferocytosis)+on+chronic+inflammatory+lung+disease&amp;author=RW+Vandivier&amp;author=PM+Henson&amp;author=IS+Douglas&amp;volume=129&amp;publication_year=2006&amp;pages=1673-1682&amp;pmid=16778289&amp;doi=10.1378/chest.129.6.1673&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Doran AC, Yurdagul A, Tabas I. Efferocytosis in health and disease. <span><span class="ref-journal">Nat. Rev. Immunol. </span>2020;<span class="ref-vol">20</span>:254–267. doi: 10.1038/s41577-019-0240-6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7667664/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31822793" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41577-019-0240-6" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Immunol.&amp;title=Efferocytosis+in+health+and+disease&amp;author=AC+Doran&amp;author=A+Yurdagul&amp;author=I+Tabas&amp;volume=20&amp;publication_year=2020&amp;pages=254-267&amp;pmid=31822793&amp;doi=10.1038/s41577-019-0240-6&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Rothlin CV, Carrera-Silva EA, Bosurgi L, Ghosh S. TAM receptor signaling in immune homeostasis. <span><span class="ref-journal">Annu. Rev. Immunol. </span>2015;<span class="ref-vol">33</span>:355–391. doi: 10.1146/annurev-immunol-032414-112103.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4491918/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25594431" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev-immunol-032414-112103" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu.+Rev.+Immunol.&amp;title=TAM+receptor+signaling+in+immune+homeostasis&amp;author=CV+Rothlin&amp;author=EA+Carrera-Silva&amp;author=L+Bosurgi&amp;author=S+Ghosh&amp;volume=33&amp;publication_year=2015&amp;pages=355-391&amp;pmid=25594431&amp;doi=10.1146/annurev-immunol-032414-112103&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. <span><span class="ref-journal">J. Immunol. </span>2007;<span class="ref-vol">178</span>:5635–5642. doi: 10.4049/jimmunol.178.9.5635.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17442946" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4049%2Fjimmunol.178.9.5635" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Immunol.&amp;title=Macrophages+and+dendritic+cells+use+different+Axl/Mertk/Tyro3+receptors+in+clearance+of+apoptotic+cells&amp;author=HM+Seitz&amp;author=TD+Camenisch&amp;author=G+Lemke&amp;author=HS+Earp&amp;author=GK+Matsushima&amp;volume=178&amp;publication_year=2007&amp;pages=5635-5642&amp;pmid=17442946&amp;doi=10.4049/jimmunol.178.9.5635&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Scott RS, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. <span><span class="ref-journal">Nature. </span>2001;<span class="ref-vol">411</span>:207–211. doi: 10.1038/35075603.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11346799" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2F35075603" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Phagocytosis+and+clearance+of+apoptotic+cells+is+mediated+by+MER&amp;author=RS+Scott&amp;volume=411&amp;publication_year=2001&amp;pages=207-211&amp;pmid=11346799&amp;doi=10.1038/35075603&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Stanford JC, et al. Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. <span><span class="ref-journal">J. Clin. Invest. </span>2014;<span class="ref-vol">124</span>:4737–4752. doi: 10.1172/JCI76375.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4347249/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25250573" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1172%2FJCI76375" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Invest.&amp;title=Efferocytosis+produces+a+prometastatic+landscape+during+postpartum+mammary+gland+involution&amp;author=JC+Stanford&amp;volume=124&amp;publication_year=2014&amp;pages=4737-4752&amp;pmid=25250573&amp;doi=10.1172/JCI76375&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Zhou Y, et al. Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP. <span><span class="ref-journal">Immunity. </span>2020;<span class="ref-vol">52</span>:357–373 e359. doi: 10.1016/j.immuni.2020.01.014.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32049051" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.immuni.2020.01.014" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Blockade+of+the+phagocytic+receptor+MerTK+on+tumor-associated+macrophages+enhances+P2X7R-dependent+STING+activation+by+tumor-derived+cGAMP&amp;author=Y+Zhou&amp;volume=52&amp;publication_year=2020&amp;pages=357-373+e359&amp;pmid=32049051&amp;doi=10.1016/j.immuni.2020.01.014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Davra V, et al. Axl and Mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity. <span><span class="ref-journal">Cancer Res. </span>2021;<span class="ref-vol">81</span>:698–712. doi: 10.1158/0008-5472.CAN-20-2066.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9999365/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33239426" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-20-2066" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=Axl+and+Mertk+receptors+cooperate+to+promote+breast+cancer+progression+by+combined+oncogenic+signaling+and+evasion+of+host+antitumor+immunity&amp;author=V+Davra&amp;volume=81&amp;publication_year=2021&amp;pages=698-712&amp;pmid=33239426&amp;doi=10.1158/0008-5472.CAN-20-2066&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Clark R, Usselmann L, Brown MR, Goeppert AU, Corrigan A. A flexible high content imaging assay for profiling macrophage efferocytosis. <span><span class="ref-journal">J. Immunol. Methods. </span>2019;<span class="ref-vol">473</span>:112636. doi: 10.1016/j.jim.2019.112636.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31369739" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jim.2019.112636" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Immunol.+Methods&amp;title=A+flexible+high+content+imaging+assay+for+profiling+macrophage+efferocytosis&amp;author=R+Clark&amp;author=L+Usselmann&amp;author=MR+Brown&amp;author=AU+Goeppert&amp;author=A+Corrigan&amp;volume=473&amp;publication_year=2019&amp;pages=112636&amp;pmid=31369739&amp;doi=10.1016/j.jim.2019.112636&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Roskoski R., Jr ERK1/2 MAP kinases: structure, function, and regulation. <span><span class="ref-journal">Pharmacol. Res. </span>2012;<span class="ref-vol">66</span>:105–143. doi: 10.1016/j.phrs.2012.04.005.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22569528" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.phrs.2012.04.005" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.+Res.&amp;title=ERK1/2+MAP+kinases:+structure,+function,+and+regulation&amp;author=R+Roskoski&amp;volume=66&amp;publication_year=2012&amp;pages=105-143&amp;pmid=22569528&amp;doi=10.1016/j.phrs.2012.04.005&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Treiber DK, Shah NP. Ins and outs of kinase DFG motifs. <span><span class="ref-journal">Chem. Biol. </span>2013;<span class="ref-vol">20</span>:745–746. doi: 10.1016/j.chembiol.2013.06.001.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23790484" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.chembiol.2013.06.001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem.+Biol.&amp;title=Ins+and+outs+of+kinase+DFG+motifs&amp;author=DK+Treiber&amp;author=NP+Shah&amp;volume=20&amp;publication_year=2013&amp;pages=745-746&amp;pmid=23790484&amp;doi=10.1016/j.chembiol.2013.06.001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Cowan-Jacob SW. Structural biology of protein tyrosine kinases. <span><span class="ref-journal">Cell. Mol. Life Sci. </span>2006;<span class="ref-vol">63</span>:2608–2625. doi: 10.1007/s00018-006-6202-8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC11136174/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17041812" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00018-006-6202-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell.+Mol.+Life+Sci.&amp;title=Structural+biology+of+protein+tyrosine+kinases&amp;author=SW+Cowan-Jacob&amp;volume=63&amp;publication_year=2006&amp;pages=2608-2625&amp;pmid=17041812&amp;doi=10.1007/s00018-006-6202-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Roskoski R. Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes. <span><span class="ref-journal">Pharmacol. Res. </span>2016;<span class="ref-vol">103</span>:26–48. doi: 10.1016/j.phrs.2015.10.021.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26529477" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.phrs.2015.10.021" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.+Res.&amp;title=Classification+of+small+molecule+protein+kinase+inhibitors+based+upon+the+structures+of+their+drug-enzyme+complexes&amp;author=R+Roskoski&amp;volume=103&amp;publication_year=2016&amp;pages=26-48&amp;pmid=26529477&amp;doi=10.1016/j.phrs.2015.10.021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Levis M, Perl AE. Gilteritinib: potent targeting of FLT3 mutations in AML. <span><span class="ref-journal">Blood Adv. </span>2020;<span class="ref-vol">4</span>:1178–1191. doi: 10.1182/bloodadvances.2019000174.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7094008/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32208491" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fbloodadvances.2019000174" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood+Adv.&amp;title=Gilteritinib:+potent+targeting+of+FLT3+mutations+in+AML&amp;author=M+Levis&amp;author=AE+Perl&amp;volume=4&amp;publication_year=2020&amp;pages=1178-1191&amp;pmid=32208491&amp;doi=10.1182/bloodadvances.2019000174&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Park TH, et al. Crystal structure of the kinase domain of MerTK in complex with AZD7762 provides clues for structure-based drug development. <span><span class="ref-journal">Int. J. Mol. Sci. </span>2020;<span class="ref-vol">21</span>:7878. doi: 10.3390/ijms21217878.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7660649/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33114206" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fijms21217878" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=Crystal+structure+of+the+kinase+domain+of+MerTK+in+complex+with+AZD7762+provides+clues+for+structure-based+drug+development&amp;author=TH+Park&amp;volume=21&amp;publication_year=2020&amp;pages=7878&amp;doi=10.3390/ijms21217878&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Yan SB, et al. LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models. <span><span class="ref-journal">Invest. N. Drugs. </span>2013;<span class="ref-vol">31</span>:833–844. doi: 10.1007/s10637-012-9912-9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3717159/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23275061" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10637-012-9912-9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest.+N.+Drugs&amp;title=LY2801653+is+an+orally+bioavailable+multi-kinase+inhibitor+with+potent+activity+against+MET,+MST1R,+and+other+oncoproteins,+and+displays+anti-tumor+activities+in+mouse+xenograft+models&amp;author=SB+Yan&amp;volume=31&amp;publication_year=2013&amp;pages=833-844&amp;doi=10.1007/s10637-012-9912-9&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Zhang J, et al. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs. <span><span class="ref-journal">Eur. J. Med. Chem. </span>2016;<span class="ref-vol">108</span>:495–504. doi: 10.1016/j.ejmech.2015.12.016.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26717201" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ejmech.2015.12.016" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Med.+Chem.&amp;title=Recent+advances+in+the+development+of+dual+VEGFR+and+c-Met+small+molecule+inhibitors+as+anticancer+drugs&amp;author=J+Zhang&amp;volume=108&amp;publication_year=2016&amp;pages=495-504&amp;pmid=26717201&amp;doi=10.1016/j.ejmech.2015.12.016&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Pflug A, et al. A-loop interactions in Mer tyrosine kinase give rise to inhibitors with two-step mechanism and long residence time of binding. <span><span class="ref-journal">Biochem. J. </span>2020;<span class="ref-vol">477</span>:4443–4452. doi: 10.1042/BCJ20200735.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7702301/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33119085" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1042%2FBCJ20200735" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+J.&amp;title=A-loop+interactions+in+Mer+tyrosine+kinase+give+rise+to+inhibitors+with+two-step+mechanism+and+long+residence+time+of+binding&amp;author=A+Pflug&amp;volume=477&amp;publication_year=2020&amp;pages=4443-4452&amp;pmid=33119085&amp;doi=10.1042/BCJ20200735&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">McCoy AJ, et al. Phaser crystallographic software. <span><span class="ref-journal">J. Appl. Crystallogr. </span>2007;<span class="ref-vol">40</span>:658–674. doi: 10.1107/S0021889807021206.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2483472/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19461840" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1107%2FS0021889807021206" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Appl.+Crystallogr.&amp;title=Phaser+crystallographic+software&amp;author=AJ+McCoy&amp;volume=40&amp;publication_year=2007&amp;pages=658-674&amp;pmid=19461840&amp;doi=10.1107/S0021889807021206&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. <span><span class="ref-journal">Acta Crystallogr. D. Biol. Crystallogr. </span>2004;<span class="ref-vol">60</span>:2126–2132. doi: 10.1107/S0907444904019158.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15572765" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1107%2FS0907444904019158" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr.+D.+Biol.+Crystallogr.&amp;title=Coot:+model-building+tools+for+molecular+graphics&amp;author=P+Emsley&amp;author=K+Cowtan&amp;volume=60&amp;publication_year=2004&amp;pages=2126-2132&amp;pmid=15572765&amp;doi=10.1107/S0907444904019158&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Afonine PV, et al. Towards automated crystallographic structure refinement with phenix.refine. <span><span class="ref-journal">Acta Crystallogr. D Biol. Crystallogr. </span>2012;<span class="ref-vol">68</span>:352–367. doi: 10.1107/S0907444912001308.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3322595/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22505256" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1107%2FS0907444912001308" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr.+D+Biol.+Crystallogr.&amp;title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&amp;author=PV+Afonine&amp;volume=68&amp;publication_year=2012&amp;pages=352-367&amp;pmid=22505256&amp;doi=10.1107/S0907444912001308&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Bong SM, et al. Regulation of mRNA export through API5 and nuclear FGF2 interaction. <span><span class="ref-journal">Nucleic Acids Res. </span>2020;<span class="ref-vol">48</span>:6340–6352. doi: 10.1093/nar/gkaa335.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7293033/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32383752" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fnar%2Fgkaa335" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res.&amp;title=Regulation+of+mRNA+export+through+API5+and+nuclear+FGF2+interaction&amp;author=SM+Bong&amp;volume=48&amp;publication_year=2020&amp;pages=6340-6352&amp;pmid=32383752&amp;doi=10.1093/nar/gkaa335&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="mixed-citation">Xing, Y. &#x00026; Hogquist, K. A. Isolation, identification, and purification of murine thymic epithelial cells. <em>J. Vis. Exp</em>. e51780 (2014). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4374365/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25145384" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Kim H, et al. A quenched annexin V-fluorophore for the real-time fluorescence imaging of apoptotic processes in vitro and in vivo. <span><span class="ref-journal">Adv. Sci. </span>2020;<span class="ref-vol">7</span>:2002988. doi: 10.1002/advs.202002988.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7740095/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33344139" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fadvs.202002988" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv.+Sci.&amp;title=A+quenched+annexin+V-fluorophore+for+the+real-time+fluorescence+imaging+of+apoptotic+processes+in+vitro+and+in+vivo&amp;author=H+Kim&amp;volume=7&amp;publication_year=2020&amp;pages=2002988&amp;doi=10.1002/advs.202002988&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Kim DK, et al. O-GlcNAcylation of Sox2 at threonine 258 regulates the self-renewal and early cell fate of embryonic stem cells. <span><span class="ref-journal">Exp. Mol. Med. </span>2021;<span class="ref-vol">53</span>:1759–1768. doi: 10.1038/s12276-021-00707-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8639819/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34819616" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs12276-021-00707-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp.+Mol.+Med.&amp;title=O-GlcNAcylation+of+Sox2+at+threonine+258+regulates+the+self-renewal+and+early+cell+fate+of+embryonic+stem+cells&amp;author=DK+Kim&amp;volume=53&amp;publication_year=2021&amp;pages=1759-1768&amp;pmid=34819616&amp;doi=10.1038/s12276-021-00707-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Poojan S, et al. Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment. <span><span class="ref-journal">Exp. Mol. Med. </span>2020;<span class="ref-vol">52</span>:1102–1115. doi: 10.1038/s12276-020-0464-3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8080688/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32661348" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs12276-020-0464-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp.+Mol.+Med.&amp;title=Cancer+cells+undergoing+epigenetic+transition+show+short-term+resistance+and+are+transformed+into+cells+with+medium-term+resistance+by+drug+treatment&amp;author=S+Poojan&amp;volume=52&amp;publication_year=2020&amp;pages=1102-1115&amp;pmid=32661348&amp;doi=10.1038/s12276-020-0464-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Ling L, Templeton D, Kung HJ. Identification of the major autophosphorylation sites of Nyk/Mer, an NCAM-related receptor tyrosine kinase. <span><span class="ref-journal">J. Biol. Chem. </span>1996;<span class="ref-vol">271</span>:18355–18362. doi: 10.1074/jbc.271.31.18355.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8702477" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.271.31.18355" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.&amp;title=Identification+of+the+major+autophosphorylation+sites+of+Nyk/Mer,+an+NCAM-related+receptor+tyrosine+kinase&amp;author=L+Ling&amp;author=D+Templeton&amp;author=HJ+Kung&amp;volume=271&amp;publication_year=1996&amp;pages=18355-18362&amp;pmid=8702477&amp;doi=10.1074/jbc.271.31.18355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Zhang W, et al. Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors. <span><span class="ref-journal">J. Med. Chem. </span>2013;<span class="ref-vol">56</span>:9683–9692. doi: 10.1021/jm401387j.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3980660/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24195762" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1021%2Fjm401387j" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Med.+Chem.&amp;title=Pseudo-cyclization+through+intramolecular+hydrogen+bond+enables+discovery+of+pyridine+substituted+pyrimidines+as+new+Mer+kinase+inhibitors&amp;author=W+Zhang&amp;volume=56&amp;publication_year=2013&amp;pages=9683-9692&amp;pmid=24195762&amp;doi=10.1021/jm401387j&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Schwende H, Fitzke E, Ambs P, Dieter P. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. <span><span class="ref-journal">J. Leukoc. Biol. </span>1996;<span class="ref-vol">59</span>:555–561. doi: 10.1002/jlb.59.4.555.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8613704" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjlb.59.4.555" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Leukoc.+Biol.&amp;title=Differences+in+the+state+of+differentiation+of+THP-1+cells+induced+by+phorbol+ester+and+1,25-dihydroxyvitamin+D3&amp;author=H+Schwende&amp;author=E+Fitzke&amp;author=P+Ambs&amp;author=P+Dieter&amp;volume=59&amp;publication_year=1996&amp;pages=555-561&amp;pmid=8613704&amp;doi=10.1002/jlb.59.4.555&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Miksa M, Komura H, Wu R, Shah KG, Wang P. A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester. <span><span class="ref-journal">J. Immunol. Methods. </span>2009;<span class="ref-vol">342</span>:71–77. doi: 10.1016/j.jim.2008.11.019.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2675277/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19135446" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jim.2008.11.019" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Immunol.+Methods&amp;title=A+novel+method+to+determine+the+engulfment+of+apoptotic+cells+by+macrophages+using+pHrodo+succinimidyl+ester&amp;author=M+Miksa&amp;author=H+Komura&amp;author=R+Wu&amp;author=KG+Shah&amp;author=P+Wang&amp;volume=342&amp;publication_year=2009&amp;pages=71-77&amp;pmid=19135446&amp;doi=10.1016/j.jim.2008.11.019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Kizawa Y, Furuya M, Saito K, Masuko T, Kusama T. Effects of dexamethasone and aminophylline on survival of Jurkat and HL-60 cells. <span><span class="ref-journal">Biol. Pharm. Bull. </span>2006;<span class="ref-vol">29</span>:281–285. doi: 10.1248/bpb.29.281.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16462032" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1248%2Fbpb.29.281" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biol.+Pharm.+Bull.&amp;title=Effects+of+dexamethasone+and+aminophylline+on+survival+of+Jurkat+and+HL-60+cells&amp;author=Y+Kizawa&amp;author=M+Furuya&amp;author=K+Saito&amp;author=T+Masuko&amp;author=T+Kusama&amp;volume=29&amp;publication_year=2006&amp;pages=281-285&amp;pmid=16462032&amp;doi=10.1248/bpb.29.281&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Storvold GL, et al. Quantitative profiling of tyrosine phosphorylation revealed changes in the activity of the T cell receptor signaling pathway upon cisplatin-induced apoptosis. <span><span class="ref-journal">J. Proteom. </span>2013;<span class="ref-vol">91</span>:344–357. doi: 10.1016/j.jprot.2013.07.019.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23933134" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jprot.2013.07.019" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Proteom.&amp;title=Quantitative+profiling+of+tyrosine+phosphorylation+revealed+changes+in+the+activity+of+the+T+cell+receptor+signaling+pathway+upon+cisplatin-induced+apoptosis&amp;author=GL+Storvold&amp;volume=91&amp;publication_year=2013&amp;pages=344-357&amp;doi=10.1016/j.jprot.2013.07.019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Pidwill GR, Gibson JF, Cole J, Renshaw SA, Foster SJ. The role of macrophages in <em>Staphylococcus aureus</em> infection. <span><span class="ref-journal">Front. Immunol. </span>2020;<span class="ref-vol">11</span>:620339. doi: 10.3389/fimmu.2020.620339.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7850989/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33542723" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffimmu.2020.620339" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Immunol.&amp;title=The+role+of+macrophages+in+Staphylococcus+aureus+infection&amp;author=GR+Pidwill&amp;author=JF+Gibson&amp;author=J+Cole&amp;author=SA+Renshaw&amp;author=SJ+Foster&amp;volume=11&amp;publication_year=2020&amp;pages=620339&amp;pmid=33542723&amp;doi=10.3389/fimmu.2020.620339&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Casella JF, Flanagan MD, Lin S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. <span><span class="ref-journal">Nature. </span>1981;<span class="ref-vol">293</span>:302–305. doi: 10.1038/293302a0.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7196996" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2F293302a0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Cytochalasin+D+inhibits+actin+polymerization+and+induces+depolymerization+of+actin+filaments+formed+during+platelet+shape+change&amp;author=JF+Casella&amp;author=MD+Flanagan&amp;author=S+Lin&amp;volume=293&amp;publication_year=1981&amp;pages=302-305&amp;pmid=7196996&amp;doi=10.1038/293302a0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Sausville E, et al. Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors. <span><span class="ref-journal">Cancer Chemother. Pharmacol. </span>2014;<span class="ref-vol">73</span>:539–549. doi: 10.1007/s00280-014-2380-5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4486055/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24448638" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00280-014-2380-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Chemother.+Pharmacol.&amp;title=Phase+I+dose-escalation+study+of+AZD7762,+a+checkpoint+kinase+inhibitor,+in+combination+with+gemcitabine+in+US+patients+with+advanced+solid+tumors&amp;author=E+Sausville&amp;volume=73&amp;publication_year=2014&amp;pages=539-549&amp;pmid=24448638&amp;doi=10.1007/s00280-014-2380-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Dhillon S. Gilteritinib: first global approval. <span><span class="ref-journal">Drugs. </span>2019;<span class="ref-vol">79</span>:331–339. doi: 10.1007/s40265-019-1062-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30721452" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs40265-019-1062-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Gilteritinib:+first+global+approval&amp;author=S+Dhillon&amp;volume=79&amp;publication_year=2019&amp;pages=331-339&amp;pmid=30721452&amp;doi=10.1007/s40265-019-1062-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Mori M, et al. Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia. <span><span class="ref-journal">Invest. N. Drugs. </span>2017;<span class="ref-vol">35</span>:556–565. doi: 10.1007/s10637-017-0470-z.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5613053/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28516360" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10637-017-0470-z" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest.+N.+Drugs&amp;title=Gilteritinib,+a+FLT3/AXL+inhibitor,+shows+antileukemic+activity+in+mouse+models+of+FLT3+mutated+acute+myeloid+leukemia&amp;author=M+Mori&amp;volume=35&amp;publication_year=2017&amp;pages=556-565&amp;doi=10.1007/s10637-017-0470-z&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Doi T, et al. Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study. <span><span class="ref-journal">Cancer Med. </span>2021;<span class="ref-vol">10</span>:6579–6589. doi: 10.1002/cam4.4110.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8495281/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34499416" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fcam4.4110" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Med.&amp;title=Merestinib+monotherapy+or+in+combination+for+japanese+patients+with+advanced+and/or+metastatic+cancer:+A+phase+1+study&amp;author=T+Doi&amp;volume=10&amp;publication_year=2021&amp;pages=6579-6589&amp;pmid=34499416&amp;doi=10.1002/cam4.4110&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Borzilleri RM, Fargnoli J. 96 Discovery of BMS-817378: a novel prodrug of the dual Met/VEGFR-2 inhibitor BMS-794833. <span><span class="ref-journal">EJC Suppl. </span>2010;<span class="ref-vol">8</span>:38. doi: 10.1016/S1359-6349(10)71801-2.</span> [<a href="//doi.org/10.1016%2FS1359-6349(10)71801-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EJC+Suppl.&amp;title=96+Discovery+of+BMS-817378:+a+novel+prodrug+of+the+dual+Met/VEGFR-2+inhibitor+BMS-794833&amp;author=RM+Borzilleri&amp;author=J+Fargnoli&amp;volume=8&amp;publication_year=2010&amp;pages=38&amp;doi=10.1016/S1359-6349(10)71801-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Nishida-Aoki N, Gujral TS. Polypharmacologic reprogramming of tumor-associated macrophages toward an inflammatory phenotype. <span><span class="ref-journal">Cancer Res. </span>2022;<span class="ref-vol">82</span>:433–446. doi: 10.1158/0008-5472.CAN-21-1428.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8847322/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34903600" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-21-1428" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=Polypharmacologic+reprogramming+of+tumor-associated+macrophages+toward+an+inflammatory+phenotype&amp;author=N+Nishida-Aoki&amp;author=TS+Gujral&amp;volume=82&amp;publication_year=2022&amp;pages=433-446&amp;pmid=34903600&amp;doi=10.1158/0008-5472.CAN-21-1428&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">McIver AL, et al. Discovery of macrocyclic pyrimidines as MerTK-specific inhibitors. <span><span class="ref-journal">ChemMedChem. </span>2017;<span class="ref-vol">12</span>:207–213. doi: 10.1002/cmdc.201600589.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5336325/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28032464" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fcmdc.201600589" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem&amp;title=Discovery+of+macrocyclic+pyrimidines+as+MerTK-specific+inhibitors&amp;author=AL+McIver&amp;volume=12&amp;publication_year=2017&amp;pages=207-213&amp;pmid=28032464&amp;doi=10.1002/cmdc.201600589&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Linger RM, et al. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. <span><span class="ref-journal">Oncogene. </span>2013;<span class="ref-vol">32</span>:3420–3431. doi: 10.1038/onc.2012.355.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3502700/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22890323" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fonc.2012.355" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Mer+or+Axl+receptor+tyrosine+kinase+inhibition+promotes+apoptosis,+blocks+growth+and+enhances+chemosensitivity+of+human+non-small+cell+lung+cancer&amp;author=RM+Linger&amp;volume=32&amp;publication_year=2013&amp;pages=3420-3431&amp;pmid=22890323&amp;doi=10.1038/onc.2012.355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Minson KA, et al. The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia. <span><span class="ref-journal">JCI Insight. </span>2016;<span class="ref-vol">1</span>:e85630. doi: 10.1172/jci.insight.85630.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4855528/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27158668" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1172%2Fjci.insight.85630" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JCI+Insight&amp;title=The+MERTK/FLT3+inhibitor+MRX-2843+overcomes+resistance-conferring+FLT3+mutations+in+acute+myeloid+leukemia&amp;author=KA+Minson&amp;volume=1&amp;publication_year=2016&amp;pages=e85630&amp;pmid=27158668&amp;doi=10.1172/jci.insight.85630&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Rios-Doria J, et al. A potent and selective dual inhibitor of AXL and MERTK possesses both immunomodulatory and tumor-targeted activity. <span><span class="ref-journal">Front. Oncol. </span>2020;<span class="ref-vol">10</span>:598477. doi: 10.3389/fonc.2020.598477.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7793849/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33425754" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffonc.2020.598477" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Oncol.&amp;title=A+potent+and+selective+dual+inhibitor+of+AXL+and+MERTK+possesses+both+immunomodulatory+and+tumor-targeted+activity&amp;author=J+Rios-Doria&amp;volume=10&amp;publication_year=2020&amp;pages=598477&amp;pmid=33425754&amp;doi=10.3389/fonc.2020.598477&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Schutters K, et al. Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells. <span><span class="ref-journal">Cell Death Differ. </span>2013;<span class="ref-vol">20</span>:49–56. doi: 10.1038/cdd.2012.107.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3524641/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22955945" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fcdd.2012.107" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Differ.&amp;title=Cell+surface-expressed+phosphatidylserine+as+therapeutic+target+to+enhance+phagocytosis+of+apoptotic+cells&amp;author=K+Schutters&amp;volume=20&amp;publication_year=2013&amp;pages=49-56&amp;pmid=22955945&amp;doi=10.1038/cdd.2012.107&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Lee HN, Surh YJ. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. <span><span class="ref-journal">Biochem. Pharmacol. </span>2013;<span class="ref-vol">86</span>:759–769. doi: 10.1016/j.bcp.2013.07.002.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23856291" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bcp.2013.07.002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+Pharmacol.&amp;title=Resolvin+D1-mediated+NOX2+inactivation+rescues+macrophages+undertaking+efferocytosis+from+oxidative+stress-induced+apoptosis&amp;author=HN+Lee&amp;author=YJ+Surh&amp;volume=86&amp;publication_year=2013&amp;pages=759-769&amp;pmid=23856291&amp;doi=10.1016/j.bcp.2013.07.002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Zang L, et al. Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells. <span><span class="ref-journal">Arch. Biochem. Biophys. </span>2012;<span class="ref-vol">518</span>:31–41. doi: 10.1016/j.abb.2011.11.019.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22155150" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.abb.2011.11.019" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch.+Biochem.+Biophys.&amp;title=Autophagy+enhanced+phagocytosis+of+apoptotic+cells+by+oridonin-treated+human+histocytic+lymphoma+U937+cells&amp;author=L+Zang&amp;volume=518&amp;publication_year=2012&amp;pages=31-41&amp;pmid=22155150&amp;doi=10.1016/j.abb.2011.11.019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Eisenberg D, Schwarz E, Komaromy M, Wall R. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. <span><span class="ref-journal">J. Mol. Biol. </span>1984;<span class="ref-vol">179</span>:125–142. doi: 10.1016/0022-2836(84)90309-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6502707" ref="reftype=pubmed&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0022-2836(84)90309-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Mol.+Biol.&amp;title=Analysis+of+membrane+and+surface+protein+sequences+with+the+hydrophobic+moment+plot&amp;author=D+Eisenberg&amp;author=E+Schwarz&amp;author=M+Komaromy&amp;author=R+Wall&amp;volume=179&amp;publication_year=1984&amp;pages=125-142&amp;pmid=6502707&amp;doi=10.1016/0022-2836(84)90309-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9534909&amp;issue-id=418614&amp;journal-id=872&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Experimental &#x0026; Molecular Medicine</span> are provided here courtesy of <strong>Korean Society for Biochemistry and Molecular Biology</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC9534909/pdf/12276_2022_Article_840.pdf" class="int-view">PDF (6.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/9534909/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/9534909/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="9534909" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9534909%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="tGkmxj1QaS5Ttom3Sgx5QI8oCoWwLSOmtzYaGLwrR8oXSJFChayOsYS61k9qNxvD">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9534909%2F&amp;text=BMS794833%20inhibits%20macrophage%20efferocytosis%20by%20directly%20binding%20to%20MERTK%20and%20inhibiting%20its%20activity" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9534909%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534909/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC9534909/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/36056187/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC9534909/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/36056187/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC9534909/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/9534909/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC9534909/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
